We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICH Guideline Suggests ‘Weight of Evidence’ Analysis Before Nonclinical Pediatric Trials
ICH Guideline Suggests ‘Weight of Evidence’ Analysis Before Nonclinical Pediatric Trials
Sponsors should consider whether they need to conduct nonclinical safety experiments on drugs before moving on to pediatric trials, according to an ICH draft guideline the FDA released for comment on Tuesday.